Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
E Ernst Department of
Complementary Medicine, School of Postgraduate Medicine and Health
Sciences, University of Exeter, Exeter EX2 4NT
Correspondence to: E.Ernst{at}ex.ac.uk
Complementary and alternative medicine is defined as
"diagnosis, treatment and/or prevention which complements mainstream medicine by contributing to a common whole, by satisfying a demand not
met by orthodoxy or by diversifying the conceptual frameworks of
medicine."1 It comprises a confusingly large and
heterogeneous array of techniques, with both therapeutic and diagnostic
approaches (table 1).
Table 1.
A recent telephone survey on the use of complementary and
alternative medicine in the United Kingdom yielded a one year
prevalence of 20%.14 Herbalism, aromatherapy,
homoeopathy, acupuncture, massage, and reflexology were among the most
popular. This level of use may seem impressive but, compared with other
countries, it is low (figure). National differences are difficult to
interpret. To some they indicate that in the United Kingdom
complementary and alternative medicine will grow to match its
popularity in Germany or France, where, contrary to the United Kingdom,
it is mostly practised by medically trained
doctors.
The exact reasons for the popularity of complementary and
alternative medicine are complex; they change with time and space, they
may vary from therapy to therapy, and they are different from one
individual to another In essence, therefore, no single determinant of the present popularity
of complementary and alternative medicine exists, but there is a broad
range of interacting positive and negative motivations. Some of these
amount to a biting criticism of our modern healthcare system.
Regardless of whether this criticism is valid or not, it is often
deeply felt by those who turn towards complementary and alternative
medicine, and mainstream medicine would be well advised to consider it
seriously.
Positive motivations
Negative motivations
Many providers of complementary and alternative medicine are
convinced that their therapy defies the "straightjacket" of
reductionist research. They argue that it is individualised, holistic,
intuitive, etc, and call for a "paradigm shift" in research.
Usually these arguments are based on a series of misunderstandings, and
often the problems can be resolved by clearly defining the research question and subsequently finding the research tool that optimally matches it. If the aim is to test the effectiveness of complementary and alternative medicine, randomised controlled trials usually provide
the least biased method for finding a reliable
answer.17
While few obstacles to research exist in principle, there are many in
practice. Complementary and alternative medicine lacks both a research
tradition and a research infrastructure and therefore fails to attract
experienced researchers. Most importantly perhaps, the orthodox
attitude remains highly (some would say destructively) sceptical, and
as a consequence the funding of research is dismal.18
Numerous indicators suggest that complementary and alternative
medicine is largely opinion based. In the course of writing a strictly
evidence based reference book of complementary and alternative
medicine, I extracted all complementary therapies recommended for
defined medical conditions in seven recent and seemingly authoritative
books on the subject. Subsequently, I contrasted the results with the
hard evidence from systematic reviews. More than 100 different
complementary therapies were recommended for asthma, while systematic
reviews failed to back up a single treatment for this
indication.19 There was little agreement between the seven
books. For instance, rarely was one treatment for asthma recommended by
more than two authors. The exceptions were acupuncture, which was
backed by four authors, and homoeopathy, which was backed by six
authors. Yet neither of these treatments was supported by acceptable
evidence.
20 21
Even more surprisingly, less than
half of these authors recommended St John's wort for depression, which
happens to be of proved effectiveness.7 Opinions that
often contradict the existing evidence seem to dominate complementary
and alternative medicine, and this highlights the necessity of bringing
opinion into line with evidence. The best way to achieve this is
through rigorous research and the broad dissemination of its findings.
If there are no funds there will be no research. If there is no
research, we will be unable to find out whether complementary and
alternative medicine does more good than harm. Yet this is the central
question destined to determine its role in future health care. Simple
answers or broad generalisations are not possible. Each of the numerous
techniques has to be evaluated separately and on its own merits. Some
forms of complementary and alternative medicine are safe but others
aren't; some are effective while others may be pure placebos (see
table 1).
It seems blatantly obvious that only well designed clinical
investigations can establish the truth. Those who would prefer to
bypass rigorous research The lack of evidence plagues large sections of complementary and
alternative medicine. For a few treatments, however, our knowledge is
sufficiently advanced to allow preliminary risk benefit analyses (see
table 1). In some cases (for example, ginkgo biloba for
intermittent claudication) the balance is positive8; in other instances (for example, chelation therapy for intermittent claudication) it is negative.5 This underscores the point
made earlier: generalisations are not possible, and those who offer them must be listened to with scepticism.
The principle of "net benefit" should also include costs.
Complementary and alternative medicine is not cheap. Extrapolation from
the results of the telephone survey,14 suggests that
Britain's annual expenditure is around £1.6 billion, and providers'
fees are considerable (table 2).22 But costs
must not be viewed in isolation; the real question is whether the use
of complementary and alternative medicine increases or decreases
overall expenditure in our healthcare system. To answer it, one would
require reliable cost evaluation studies. Few such investigations are
available to date, the most rigorous of which negate the hypothesis
that use of complementary and alternative medicine reduces overall expenditure.23
Table 2.
It has been pointed out repeatedly that complementary and
alternative medicine can be "ineffective" (in the sense of not
being better than a placebo) and still do a world of good to the
wellbeing of our patients.24 Some argue that complementary
and alternative medicine should be used regardless of the results of
placebo controlled clinical trials, particularly when its use is not
associated with serious risks (see table 1). In such cases,
rigorous research could even be seen as counterproductive. We might,
for instance, find little "hard" evidence in favour of
aromatherapy; if its "ineffectiveness" became known its
availability would decrease, and yet aromatherapy could considerably
help patients through its non-specific effects.24
Such arguments cannot be used against the rigorous investigation of
complementary and alternative medicine. If research really showed that
aromatherapy has no adverse effects and helps people through
powerful non-specific (placebo) effects, the medical community should
start seriously considering the power of placebos. The research
question then shifts to how non-specific effects might be optimised so
that more patients (not just those seeing an aromatherapist) can
profit from them. Even in this (worst case) scenario, research would
yield clinically valuable information.
We should listen less to the opinions of those who either overtly
promote or stubbornly reject complementary and alternative medicine
without acceptable evidence. The many patients who use complementary
and alternative medicine deserve better. Patients and healthcare
providers need to know which forms are safe and effective. Its future
should (and hopefully will) be determined by unbiased scientific evaluation.
Summary points
The one year prevalence for use of complementary and alternative
medicine is around 20% and is predicted to rise
Some of the reasons for this popularity amount to a biting criticism of
conventional medicine
At present much complementary and alternative medicine is still opinion
based
![]()
Complementary and alternative medicine is popular

View larger version (18K):
[in a new window]
One year prevalence of complementary and alternative medicine in
various countries. Data based on surveys of random or representative
samples of population
![]()
Complex reasons for popularity
for example, a patient with AIDS will have other
motives than someone who is "worried well." Reporting on
complementary and alternative medicine in the British daily press is
considerably more enthusiastic than that for conventional medicine.15 Also complementary and alternative medicine is
largely practised privately. There is an intriguing, positive
correlation between signs of affluence and the sales figures of
commercial complementary and alternative medicine
products.16
Motivations for trying complementary and alternative medicine
![]()
Difficulties in research
![]()
Opinion based medicine
![]()
Hard evidence is scarce
for example, by shifting the discussion towards patients' preference
and hope to integrate unproved
treatments into routine health care are unlikely to succeed in the long
run. Those who believe that regulation is a substitute for evidence will find that even the most meticulous regulation of nonsense must
still result in nonsense. And those who insist that the evidence to
support complementary and alternative medicine can legitimately be
softer than in mainstream medicine will have to reconsider their
position. Double standards in medicine existed for many years;
undoubtedly they still exist today, but hopefully their days are numbered.
![]()
Association with powerful non-specific effects
![]()
Conclusion
| |
Acknowledgments |
|---|
This is an edited version of a presentation at the the Millennium Festival of Medicine in London, 6-10 November 2000.
| |
Footnotes |
|---|
Competing interests: None declared.
| |
References |
|---|
| 1. |
Ernst E, Resch KL, Mills S, Hill R, Mitchell A, Willoughby M, et al.
Complementary medicine a definition.
Br J Gen Pract
1995;
45:
506[Medline].
|
| 2. | Ezzo J, Berman B, Hadhazy VA, Jadad JR, Lao L, Singh BB. Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain 2000; 86: 217-225[CrossRef][Medline]. |
| 3. |
Lee A, Done ML.
The use of non-pharmacologic techniques to prevent postoperative nausea and vomiting: a meta-analysis.
Anesth Analg
1999;
88:
1362-1369 |
| 4. | Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract 2000; 50: 493-496[Medline]. |
| 5. | Ernst E. Chelation therapy for peripheral arterial occlusive disease. Circulation 1997; 96: 1031-1033[Medline]. |
| 6. | Bronford G. Spinal manipulation. Current state of research and its indications. Neurol Clin North Am 1999; 17: 91-111. |
| 7. |
Williams JW, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J.
A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
Ann Intern Med
2000;
132:
743-756 |
| 8. | Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000; 108: 226-281. |
| 9. | Linde K, Claudius N, Ramirez G, Melchart D, Eitel F, Hedges LV, et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo controlled trials. Lancet 1997; 350: 834-843[CrossRef][Medline]. |
| 10. |
Ernst E.
Iridology not useful and potentially harmful.
Arch Opthalmol
2000;
118:
120-121 |
| 11. | Ernst E. Massage therapy for low pack pain: a systematic review. J Pain Symptom Manage 1999; 17: 65-69[CrossRef][Medline]. |
| 12. |
Astin JA, Harkness E, Ernst E.
The efficacy of "distant healing": a systematic review of randomized trials.
Ann Intern Med
2000;
132:
903-910 |
| 13. | Ernst E, Köder K. An overview of reflexology. Eur J Gen Pract 1997; 3: 52-57. |
| 14. | Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complement Ther Med 2000; 8: 32-36[Medline]. |
| 15. |
Ernst E, Weihmayr T.
UK and German media differ over complementary medicine.
BMJ
2000;
321:
707 |
| 16. |
Ernst E.
Alternative views on alternative medicine.
Ann Intern Med
1999;
131:
229-230 |
| 17. | Vickers A, Cassileth B, Ernst E, Fisher P, Goldman P, Jonas W, et al. How should we research unconventional therapies? A report from the conference on complementary and alternative medicine research methodology, National Institute of Health. Int J Technol Assess Health Care 1997; 13: 111-121[Medline]. |
| 18. | Ernst E. Funding research into complementary medicine: the situation in Britain. Complement Ther Med 1999; 7: 250-253[CrossRef][Medline]. |
| 19. | Ernst E, ed. Complementary and alternative medicine. A desk top reference. London: Mosby (in press). |
| 20. | Linde K, Jobst K, Panton J. Acupuncture for the treatment of bronchial asthma. In: Cochrane Collaboration,ed. Cochrane Library. Issue 3. Oxford: Update Software, 1997. |
| 21. | Linde K, Jobst KA. Homeopathy for chronic asthma. In: Cochrane Collaboration,ed. Cochrane Library. Issue 2. Oxford: Update Software, 2000. |
| 22. | White AR, Resch KL, Ernst E. A survey of complementary practitioners' fees, practice, and attitudes to working within the National Health Service. Complement Ther Med 1997; 5: 210-214[CrossRef]. |
| 23. | White AR, Ernst E. Economic analysis of complementary medicine: a systematic review. Complement Ther Med 2000; 8: 111-118[CrossRef][Medline]. |
| 24. | Vickers A. Why aromatherapy works (even if it doesn't) and why we need less research. Br J Gen Pract 2000; 50: 444-445[Medline]. |
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+